Overview
Sarah Huet practices in Pierre-la-treiche, France. Ms. Huet is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Leukemia, and Hairy Cell Leukemia (HCL).
Her clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Chronic B-Cell Leukemia (CBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Follicular LymphomaMs. Huet isDistinguished. Learn about Follicular Lymphoma.
- Advanced
- LeukemiaMs. Huet isAdvanced. Learn about Leukemia.
- Non-Hodgkin LymphomaMs. Huet isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Huet isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Angioimmunoblastic T-cell LymphomaMs. Huet isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaMs. Huet isExperienced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Ms. Huet isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Huet isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Ms. Huet isExperienced. Learn about Chronic Myelogenous Leukemia (CML).